Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Aug 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
Most recent update: Mar 2024
Source: Statista Market Insights
The General & Plastic Surgery Devices market in Germany is experiencing steady growth due to customer preferences for advanced and innovative surgical devices, increasing demand for aesthetic procedures, and favorable local special circumstances. Customer preferences in the General & Plastic Surgery Devices market in Germany are driving the growth of the market. German customers value quality and precision in surgical procedures, leading to a high demand for technologically advanced surgical devices. They are willing to invest in state-of-the-art equipment that can provide better surgical outcomes and minimize risks. Additionally, German customers have a strong preference for minimally invasive procedures, which require specialized surgical devices. Trends in the General & Plastic Surgery Devices market in Germany include the adoption of robotic-assisted surgical devices, the increasing popularity of non-invasive cosmetic procedures, and the integration of digital technologies in surgical devices. Robotic-assisted surgical devices offer improved precision, control, and visualization, leading to better surgical outcomes. Non-invasive cosmetic procedures, such as laser treatments and injectables, are gaining popularity in Germany due to their minimal downtime and natural-looking results. The integration of digital technologies, such as augmented reality and artificial intelligence, in surgical devices is enhancing surgical planning and decision-making processes. Local special circumstances in Germany contribute to the growth of the General & Plastic Surgery Devices market. Germany has a well-developed healthcare system with high standards of patient care, which creates a favorable environment for the adoption of advanced surgical devices. The country also has a large aging population, which increases the demand for plastic surgery procedures to address age-related concerns. Additionally, Germany is known for its medical tourism industry, attracting patients from around the world who seek high-quality medical treatments, including plastic surgery. Underlying macroeconomic factors, such as the overall economic growth of Germany and government healthcare policies, also impact the General & Plastic Surgery Devices market. A strong economy provides individuals with more disposable income, allowing them to invest in elective surgical procedures. Government healthcare policies that support reimbursement for certain plastic surgery procedures can also drive the demand for surgical devices. In conclusion, the General & Plastic Surgery Devices market in Germany is developing due to customer preferences for advanced surgical devices, increasing demand for aesthetic procedures, favorable local special circumstances, and underlying macroeconomic factors. The market is expected to continue growing as technology advances and customer demand for minimally invasive and non-invasive procedures increases.
Most recent update: Aug 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights